T. Rowe Price Associates’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.71M | Sell |
846,261
-59,923
| -7% | -$192K | ﹤0.01% | 1511 |
|
|
2025
Q1 | $3.67M | Sell |
906,184
-21,722
| -2% | -$88K | ﹤0.01% | 1355 |
|
|
2024
Q4 | $9.84M | Sell |
927,906
-7,253
| -0.8% | -$76.9K | ﹤0.01% | 1149 |
|
|
2024
Q3 | $23.1M | Sell |
935,159
-16,204
| -2% | -$400K | ﹤0.01% | 964 |
|
|
2024
Q2 | $26.8M | Buy |
951,363
+63,527
| +7% | +$1.79M | ﹤0.01% | 883 |
|
|
2024
Q1 | $36.1M | Buy |
887,836
+195,219
| +28% | +$7.95M | ﹤0.01% | 812 |
|
|
2023
Q4 | $11.4M | Sell |
692,617
-52,853
| -7% | -$872K | ﹤0.01% | 1066 |
|
|
2023
Q3 | $28.3M | Sell |
745,470
-3,948
| -0.5% | -$150K | ﹤0.01% | 831 |
|
|
2023
Q2 | $41.2M | Sell |
749,418
-15,002
| -2% | -$825K | 0.01% | 754 |
|
|
2023
Q1 | $32.9M | Buy |
764,420
+38,315
| +5% | +$1.65M | ﹤0.01% | 799 |
|
|
2022
Q4 | $28.5M | Sell |
726,105
-13,452
| -2% | -$529K | ﹤0.01% | 822 |
|
|
2022
Q3 | $39.3M | Sell |
739,557
-153,604
| -17% | -$8.16M | 0.01% | 719 |
|
|
2022
Q2 | $58.6M | Buy |
893,161
+16,792
| +2% | +$1.1M | 0.01% | 826 |
|
|
2022
Q1 | $64.3M | Buy |
876,369
+11,657
| +1% | +$856K | 0.01% | 884 |
|
|
2021
Q4 | $61.2M | Buy |
864,712
+1,890
| +0.2% | +$134K | 0.01% | 937 |
|
|
2021
Q3 | $216M | Buy |
862,822
+126,510
| +17% | +$31.7M | 0.02% | 528 |
|
|
2021
Q2 | $198M | Buy |
736,312
+87,858
| +14% | +$23.6M | 0.02% | 559 |
|
|
2021
Q1 | $185M | Buy |
648,454
+209,036
| +48% | +$59.5M | 0.02% | 575 |
|
|
2020
Q4 | $125M | Buy |
439,418
+7,322
| +2% | +$2.08M | 0.01% | 661 |
|
|
2020
Q3 | $129M | Buy |
432,096
+13,978
| +3% | +$4.17M | 0.01% | 588 |
|
|
2020
Q2 | $84.6M | Buy |
+418,118
| New | +$84.6M | 0.01% | 682 |
|